204 related articles for article (PubMed ID: 38634521)
1. Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy.
Zhong Z; Deng W; Wu J; Shang H; Tong Y; He Y; Huang Q; Ba X; Chen Z; Tang K
Nanoscale; 2024 May; 16(18):8708-8738. PubMed ID: 38634521
[TBL] [Abstract][Full Text] [Related]
2. The Emerging Role of Cell Membrane-coated Nanomaterials in Cancer Therapy.
Bhattacharya S; Beninger P
Curr Pharm Des; 2024 Mar; ():. PubMed ID: 38441015
[TBL] [Abstract][Full Text] [Related]
3. Cell membrane camouflaged nanoparticles: a new biomimetic platform for cancer photothermal therapy.
Wu M; Le W; Mei T; Wang Y; Chen B; Liu Z; Xue C
Int J Nanomedicine; 2019; 14():4431-4448. PubMed ID: 31354269
[TBL] [Abstract][Full Text] [Related]
4. Cell membrane coated nanoparticles: next-generation therapeutics.
Narain A; Asawa S; Chhabria V; Patil-Sen Y
Nanomedicine (Lond); 2017 Nov; 12(21):2677-2692. PubMed ID: 28965474
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
[TBL] [Abstract][Full Text] [Related]
6. Biomimetic fabrication of nanotherapeutics by leukocyte membrane cloaking for targeted therapy.
Mohale S; Kunde SS; Wairkar S
Colloids Surf B Biointerfaces; 2022 Nov; 219():112803. PubMed ID: 36084510
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy.
Raza F; Zafar H; Zhang S; Kamal Z; Su J; Yuan WE; Mingfeng Q
Adv Healthc Mater; 2021 Mar; 10(6):e2002081. PubMed ID: 33586322
[TBL] [Abstract][Full Text] [Related]
8. Cell membrane-encapsulated magnetic nanoparticles for enhancing natural killer cell-mediated cancer immunotherapy.
Wu D; Shou X; Zhang Y; Li Z; Wu G; Wu D; Wu J; Shi S; Wang S
Nanomedicine; 2021 Feb; 32():102333. PubMed ID: 33188908
[TBL] [Abstract][Full Text] [Related]
9. [Cell membrane-coated nanoparticles in disease therapy].
Li D; Xu J; Kang L; Zhao B; Wang J; Xin W
Sheng Wu Gong Cheng Xue Bao; 2024 May; 40(5):1323-1337. PubMed ID: 38783800
[TBL] [Abstract][Full Text] [Related]
10. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
11. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
[TBL] [Abstract][Full Text] [Related]
12. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis.
Beh CY; Prajnamitra RP; Chen LL; Hsieh PC
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443638
[TBL] [Abstract][Full Text] [Related]
13. Cell membrane coated nanoparticles: cutting-edge drug delivery systems for osteoporosis therapy.
Liao J; Lu L; Chu X; Xiong Y; Zhou W; Cao F; Cheng P; Shahbazi MA; Liu G; Mi B
Nanoscale; 2024 May; 16(17):8236-8255. PubMed ID: 38584466
[TBL] [Abstract][Full Text] [Related]
14. A Review of Biomimetic Nanoparticle Drug Delivery Systems Based on Cell Membranes.
Zhang M; Du Y; Wang S; Chen B
Drug Des Devel Ther; 2020; 14():5495-5503. PubMed ID: 33363358
[TBL] [Abstract][Full Text] [Related]
15. Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery.
Hao W; Cui Y; Fan Y; Chen M; Yang G; Wang Y; Yang M; Li Z; Gong W; Yang Y; Gao C
J Nanobiotechnology; 2021 Nov; 19(1):378. PubMed ID: 34801032
[TBL] [Abstract][Full Text] [Related]
16. Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy.
Han S; Huang K; Gu Z; Wu J
Nanoscale; 2020 Jan; 12(2):413-436. PubMed ID: 31829394
[TBL] [Abstract][Full Text] [Related]
17. Acid-Activated TAT Peptide-Modified Biomimetic Boron Nitride Nanoparticles for Enhanced Targeted Codelivery of Doxorubicin and Indocyanine Green: A Synergistic Cancer Photothermal and Chemotherapeutic Approach.
Li H; Fan Y; Shen Y; Xu H; Zhang H; Chen F; Feng S
ACS Appl Mater Interfaces; 2024 May; 16(19):25101-25112. PubMed ID: 38691046
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors.
Bahmani B; Gong H; Luk BT; Haushalter KJ; DeTeresa E; Previti M; Zhou J; Gao W; Bui JD; Zhang L; Fang RH; Zhang J
Nat Commun; 2021 Mar; 12(1):1999. PubMed ID: 33790276
[TBL] [Abstract][Full Text] [Related]
19. Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy.
Hussain Z; Rahim MA; Jan N; Shah H; Rawas-Qalaji M; Khan S; Sohail M; Thu HE; Ramli NA; Sarfraz RM; Abourehab MAS
J Control Release; 2021 Jul; 335():130-157. PubMed ID: 34015400
[TBL] [Abstract][Full Text] [Related]
20. Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery.
Wang H; Liu Y; He R; Xu D; Zang J; Weeranoppanant N; Dong H; Li Y
Biomater Sci; 2020 Jan; 8(2):552-568. PubMed ID: 31769765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
